Domov › Virusne okužbe › Maryland
Klinične študije za Virusne okužbe v Maryland
14 študij za Virusne okužbe išče udeležence na lokacijah v Maryland.
Mesta v Maryland
Uradno besedilo študije (angleško)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Annapolis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05624450Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevOpazovalna študija
Starost 18–120 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT00006518The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevOpazovalna študija
Starost 2–100 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT01011712Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 18–50 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07706686A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Johns Hopkins Hospital, Baltimore
- Jadestone Clinical Research, Silver Spring
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07013474A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Centennial Medical Group, Columbia
- Jadestone Clinical Research, Silver Spring
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06679140Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
- University of Maryland, Baltimore
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07654283Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 18–50 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT06863142Viral Infections in Healthy and Immunocompromised Hosts
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
6 Months – 120 Years · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT01306084Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
2 Months – 115 Years · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT04419870Genetic Studies of Chronic Active Epstein-Barr Disease
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevOpazovalna študija
Starost 1–120 · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT00032513Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
- Johns Hopkins, Baltimore
Vključevanje udeležencevFaza 1/2
1 Month – 79 Years · Vsi spoli · Posodobljeno 15. apr. 2026 · NCT04197596Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
- Johns Hopkins University, Baltimore
- National Institutes of Health (NIH), Bethesda
Vključevanje udeležencevFaza 1
3 Months – 80 Years · Vsi spoli · Posodobljeno 26. jan. 2026 · NCT04691622Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
- All Natural Medicine Clinic, LLC, Rockville
Vključevanje udeležencevFaza 1/2
Vse starosti · Vsi spoli · Posodobljeno 19. feb. 2025 · NCT04790240Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.